483 Cangene BioPharma. dba Emergent BioSolutions Mar 2017

483 Cangene BioPharma. dba Emergent BioSolutions Mar 2017

$119 - Not in Stock

FDA investigators audited the Cangene BioPharma. dba Emergent BioSolutions - Rockville, MD, United States facility and issued inspectional observations (via FDA 483) on 22 Mar 2017.

Product details

  • Category: Biologics
  • Inspection end: 22 Mar 2017
  • Location: Rockville, United States
  • FEI: 3008934776
Order